معرفی
Thomas Naderer is an Associate Professor (Research) in Biochemistry & Molecular Biology at Monash University, affiliated with the Monash Biomedicine Discovery Institute and the Centre to Impact Antimicrobial Resistance (AMR). He earned his PhD from the University of Melbourne in 2004 and established the macrophage-pathogen interaction research group in 2012 with NHMRC funding. His research focuses on understanding how microbes manipulate macrophage survival to evade immune defenses and develop novel treatment strategies for infections.
Education:
- Bachelor's degree, University of Vienna, Austria
- Masters, University of Nottingham, UK
- PhD, University of Melbourne, Australia (2004)
Research Interests:
His work investigates programmed cell death pathways in infections, bacterial vesicle-mediated host cell killing, and metabolic crosstalk between pathogens and macrophages. Recent breakthroughs include demonstrating that drugs targeting infected macrophages can combat pneumonia, fungal infections, and sexually transmitted diseases. His group also explores how superbugs disable host immune cells to persist within the body.
Key Achievements:
- Recipient of an ARC Future Fellowship (2017) to study host cell death in immune defense
- Leader of the Community Action & Empowerment working group at Monash's AMR Centre
- Principal Investigator on NHMRC- and ARC-funded projects addressing AMR and bacterial pathogenesis
Collaborations:
Active collaborations span global institutions, including studies on bacterial vesicle biology and antibiotic resistance mechanisms. He contributes to the Monash Antimicrobial Resistance Group and has engaged in interdisciplinary projects with clinical and pharmaceutical partners.
